Developmental toxicity of valproic acid.
Valproic acid is a very effective anticonvulsant agent widely used in the management of various forms of epilepsy. Administration of the drug during pregnancy results in increased incidence of congenital abnormalities in both humans and experimental animals. In recent years, a significant number of research efforts have attempted to define the contributory role of valproic acid to the impairment of normal prenatal growth and development. The present report summarizes current knowledge that has emerged from clinical and research studies. The specific topics include: the placental transfer of valproic acid; the teratogenic potential; structure-teratogenicity and dose-response relationships; species and strain differences; biochemical changes evoked by the drug in the fetus.
Cotariu
D
D
Department of Biochemical Pathology, Assaf Harofeh Medical Center, Sackler School of Medicine, Tel Aviv University, Zerifin, Israel.
Zaidman
J L
JL
D000818:Animals; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D013045:Species Specificity; D013329:Structure-Activity Relationship; D013723:Teratogens; D014635:Valproic Acid / Q000008:administration & dosage / Q000378:metabolism / Q000633:toxicity*
D013723:Teratogens; D014635:Valproic Acid